SELL STEVEN (CEO & President) received a stock award from AGILON HEALTH, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2025ACC: 0001628280-25-016679
DirectorOfficer· CEO & President
Since Apr 2021
+1.42M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.42M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+551.47K
Price / share
—
Trade value
—
% of position
155.2%
4/1/2025
355.31K→906.78K
Total
Net shares
+551.47K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2025 | A · Award | +551.47K | — | — | 155.2% | 355.31K | 906.78K |
| Total | +551.47K | $0.00 | ||||||
Derivative Transactions1
Options (Right to buy)
Direct
Converts to
Common Stock
865.38K shares
Shares
+865.38K
Strike price
4.08
Held after
865.38K
Exercisable
—
4/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options (Right to buy) Direct | Common Stock865.38K shares | 4/1/2025 | A · Award | +865.38K | 4.08 | — | 865.38K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned67.59K
Total
67.59K indirect67.59K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 67.59K | Indirect |
| Total | 67.59K | 67.59K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported